Replacement of dietary saturated fat with trans fat reduces serum paraoxonase activity in healthy men and women

Metabolism: Clinical and Experimental

Volumn 51, Issue 12, 2002, Pages 1534-1537

  De Roos, Nicole M ^a,b,c   Schouten, Evert G ^a,b,c   Scheek, Leo M ^a,b,c   Van Tol, Arie ^a,b,c   Katan, Martijn B ^a,b,c  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^c TOP INSTITUTE FOOD AND NUTRITION   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARYLDIALKYLPHOSPHATASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; SATURATED FATTY ACID;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSSOVER PROCEDURE; DIET; ENDOTHELIUM; ENDOTHELIUM INJURY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FAT INTAKE; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; STATISTICAL ANALYSIS; TRANS ISOMER; VOLUNTEER;

EID: 0036912596     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1053/meta.2002.36305     Document Type: Article

References (34)

1. Ascherio A, Katan MB, Stampfer MJ, et al: Trans fatty acids and coronary heart disease. N Engl J Med 340:1994-1998, 1999
2. Sundram K, Ismail A, Hayes KC, et al: Trans (elaidic) fatty acids adversely affect the lipoprotein profile relative to specific saturated fatty acids in humans. J Nutr 127:514S-520S, 1997
3. Almendingen K, Jordal O, Kierulf P, et al: Effects of partially hydrogenated fish oil, partially hydrogenated soybean oil, and butter on serum lipoproteins and Lp[a] in men. J Lipid Res 36:1370-1384, 1995
4. Aro A, Jauhiainen M, Partanen R, et al: Stearic acid, trans fatty acids, and dairy fat: Effects on serum and lipoprotein lipids, apolipoproteins, lipoprotein(a), and lipid transfer proteins in healthy subjects. Am J Clin Nutr 65:1419-1426, 1997
5. Judd JT, Clevidence BA, Muesing RA, et al: Dietary trans fatty acids: Effects on plasma lipids and lipoproteins of healthy men and women. Am J Clin Nutr 59:861-868, 1994
6. Kris-Etherton PM, Yu S: Individual fatty acid effects on plasma lipids and lipoproteins: Human studies. Am J Clin Nutr 65:1628S-1644S, 1997
7. Lichtenstein AH, Ausman LM, Jalbert SM, et al: Effects of different forms of dietary hydrogenated fats on serum lipoprotein cholesterol levels. N Engl J Med 340:1933-1940, 1999
8. Müller H, Jordal O, Kierulf P, et al: Replacement of partially hydrogenated soybean oil by palm oil in margarine without unfavorable effects on serum lipoproteins. Lipids 33:879-887, 1998
9. Zock PL, Katan MB: Hydrogenation alternatives: Effects of trans fatty acids and stearic acid versus linoleic acid on serum lipids and lipoproteins in humans. J Lipid Res 33:399-410, 1992
10. De Roos NM, Bots ML, Katan MB: Replacement of dietary saturated fatty acids by trans fatty acids lowers serum HDL cholesterol and impairs endothelial function in healthy men and women. Arterioscler Thromb Vasc Biol 21:1233-1237, 2001
11. Bhagat K, Hingorani A, Vallance P: Flow associated or flow mediated dilatation? More than just semantics. Heart 78:7-8, 1997
12. Navab M, Hama SY, Anantharamaiah GM, et al: Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein. Steps 2 and 3. J Lipid Res 41:1495-1508, 2000
13. Navab M, Hama SY, Cooke CJ, et al: Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein. Step 1. J Lipid Res 41:1481-1494, 2000
14. Klimov AN, Gurevich VS, Nikiforova AA, et al: Antioxidative activity of high density lipoproteins in vivo. Atherosclerosis 100:13-18, 1993
15. Graham A, Hassall DG, Rafique S, et al: Evidence for a paraoxonase-independent inhibition of low-density lipoprotein oxidation by high-density lipoprotein. Atherosclerosis 135:193-204, 1997
16. Toikka JO, Ahotupa M, Viikari JS, et al: Constantly low HDL-cholesterol concentration relates to endothelial dysfunction and increased in vivo LDL-oxidation in healthy young men. Atherosclerosis 147:133-138, 1999
17. Aviram M, Rosenblat M, Bisgaier CL, et al: Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. J Clin Invest 101:1581-1590, 1998
18. Stein O, Stein Y: Atheroprotective mechanisms of HDL. Atherosclerosis 144:285-301, 1999
19. Mackness MI, Mackness B, Durrington PN, et al: Paraoxonase and coronary heart disease. Curr Opin Lipidol 9:319-324, 1998
20. Van Der Gaag MS, Van Tol A, Scheek LM, et al: Daily moderate alcohol consumption increases serum paraoxonase activity; A diet-controlled, randomised intervention study in middle-aged men. Atherosclerosis 147:405-410, 1999
21. Sutherland WH, Walker RJ, De Jong SA, et al: Reduced post-prandial serum paraoxonase activity after a meal rich in used cooking fat. Arterioscler Thromb Vasc Biol 19:1340-1347, 1999
22. Kudchodkar BJ, Lacko AG, Dory L, et al: Dietary fat modulates serum paraoxonase 1 activity in rats. J Nutr 130:2427-2433, 2000
23. Aviram M, Dornfeld L, Rosenblat M, et al: Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: Studies in humans and in atherosclerotic apolipoprotein E-deficient mice. Am J Clin Nutr 71:1062-1076, 2000
24. James RW, Leviev I, Righetti A: Smoking is associated with reduced serum paraoxonase activity and concentration in patients with coronary artery disease. Circulation 101:2252-2257, 2000
25. Shih DM, Gu L, Xia Y-R, et al: Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis. Nature 394:284-287, 1998
26. Shih DM, Tward A, Xia Y-R, et al: Overexpression of human serum paraoxonase reduces atherosclerosis in transgenic mice. Circulation 102:II-316, 2000
27. Salonen JT, Malin R, Tuomainen TP, et al: Polymorphism in high density lipoprotein paraoxonase gene and risk of acute myocardial infarction in men: Prospective nested case-control study. BMJ 319:487-488, 1999
28. De Roos NM, Schouten EG, Bots ML, et al: Consumption of a solid fat rich in lauric acid results in a more favorable serum lipid profile in healthy men and women than consumption of a solid fat rich in trans-fatty acids. J Nutr 131:242-245, 2001
29. Feunekes GI, Van Staveren WA, De Vries JH, et al: Relative and biomarker-based validity of a food-frequency questionnaire estimating intake of fats and cholesterol. Am J Clin Nutr 58:489-96, 1993
30. Dallal GE, Wilkinson L: An analytic approximation to the distribution of Lilliefors's test statistic for normality. The American Statistician 40:294-296, 1986
31. Mackness B, Mackness MI, Durrington PN, et al: Paraoxonase activity in two healthy populations with differing rates of coronary heart disease. Eur J Clin Invest 30:4-10, 2000
32. 155 genotype. Arterioscler Thromb Vasc Biol 20:2441-2447, 2000
33. Tomás M, Sentí M, García-Faria F, et al: Effect of simvastatin therapy on paraoxonase activity and related lipoproteins in familial hypercholesterolemic patients. Arterioscler Thromb Vasc Biol 20:2113-2119, 2000
34. Bauters C, Amant C, Boulier A, et al: Paraoxonase polymorphism (Gln192Arg) as a determinant of the response of human coronary arteries to serotonin. Circulation 101:740-743, 2000